Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Active, not recruiting · NCT04541108 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, squamous cell carcinoma | Active, not recruiting | Early phase 1 | 2026-05-22 | NCT04541108 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Presage Biosciences | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| LSU Health Sciences Center - Shreveport | Shreveport | United States | 1 |
| Montefiore Medical Center | The Bronx | United States | 198 |
| MUSC Hollings Cancer Center | Charleston | United States | 9 |
| Oregon Health & Science University (OHSU) | Portland | United States | 25 |
| Sarah Cannon Research Institute | Charleston | United States | 1 |
| UC Health | Cincinnati | United States | 3 |
| University of North Carolina | Chapel Hill | United States | 101 |
| University of Pennsylvania | Philadelphia | United States | 23 |
| University of Washington | Seattle | United States | 36 |